LA
LadRx Corporation
LADX · OTC
$0.01 -89.72% (-$0.10)
Market Cap $5.45K
P/E Ratio -
Div. Yield -
ROE 159.92%
Bulios Fair Price
$0.01
9.1% downside
Current Price
$0.011
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LADX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.79x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 50,720.90%
Gross margin 3.71%
FCF margin 26,915,900.00%
Quality
70 /100
Excellent ROA 959.62%
ROIC 167.18%
Asset turnover 0.03x
Debt
70 /100
Low Net debt/EBITDA 0.06x
Current ratio 0.11x
Debt/Assets N/A
Stability
21 /100
Unstable Profitable years 0
Beta 1.25x
EPS volatility 272,727.17%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LADX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jorge Kuri Slim
Employees
2
Headquarters
Los Angeles